Just re-iterating my previous assertion (guess) that NVAX is on course for massive gains in the long-term. Doesn't mean it's a great company but this pandemic has initiated a similar pattern in the past. They have several great developments in the works: NanoFlu, RSV F, and a COVID-19 vaccine candidate. See my previous posts especially the related one.
This is purely speculation based on their pipeline. This is not financial advice.
If they have successful trials with their Covid vaccine they will be off the chart with their stock. Stop and think about it. Someone no kidding has a successful candidate for Covid. Billions of people need it. The stock will be off the chart.